AlphaYouIR
Insider selling
Ii Robert C. Goeltz sold $199K of Arcus Biosciences, Inc. (RCUS) stock
Ii Robert C. Goeltz, Chief Financial Officer of Arcus Biosciences, Inc. (RCUS), sold 7,763 shares of RCUS stock worth $199K, per an SEC Form 4 filed May 12, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on May 11, 2026, 1 day before it was made public.
RCUS has moved +4.4% since the trade date, from $24.86 to $25.95 (Sep 21, 2026 close).
- Traded
- May 11, 2026
- Disclosed
- May 12, 2026
- Filing delay
- 1 day
- Price since
- +4.4%
- Role
- Chief Financial Officer
- Source
- SEC Form 4
More RCUS insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.